Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.

Invasive Pneumococcal Disease Clinical Trial

Official title:
Effectiveness of Prevnar in the Prevention on IPD in the Paediatric Population in Spain

Status Completed

Clinical Trial Summary

The aim of this study is to evaluate the postlicensure effectiveness of Prevnar in the prevention of IPD in the Spanish paediatric population (children younger than 5 years)

Clinical Trial Description

n/a

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Invasive Pneumococcal Disease

Clinical Trial Details

NCT number	NCT00227188
Study type	Observational
Source	Pfizer
Contact
Status	Completed
Phase	N/A
Start date	May 2003
Completion date	December 2005

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00853749` - Immune Response In Children Revaccinated With Pneumococcal Conjugate Vaccine	Phase 3
Recruiting	`NCT00885625` - 7-valent Pneumococcal Conjugated Vaccination	Phase 4
Completed	`NCT04464291` - An Epidemiological Survey to Establish the Spectrum of Circulating Serotypes of S. Pneumoniae, in Patients Older 18 Years	N/A
Completed	`NCT01128439` - Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal Disease
Completed	`NCT01083459` - Impact of PCV on Disease and Colonization Among Native American Communities	N/A
Completed	`NCT00371878` - Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV Infection	Phase 4